Sign In

Philip Gutry

Chief Business Officer, Head of Finance & Investor Relations at Graphite Bio

Philip Gutry is a biopharmaceutical leader with a deep passion for translating scientific advancements into commercial products. With a robust background in finance, business development, and investor relations, he has successfully raised $1.8 billion in equity, debt, and R&D funding across more than 30 deals. Philip brings extensive financial expertise, serving as the Audit Committee Chair for a NASDAQ-listed company for five years and gaining valuable experience in executing leveraged buyouts and venture capital investments over a decade.

Educationally, Philip Gutry holds an MBA in Healthcare Management from the renowned University of Pennsylvania - The Wharton School and an AB in Earth Sciences from Dartmouth College.

In terms of organizations, Philip currently serves as the Chief Business Officer, Head of Finance & Investor Relations at Graphite Bio. He has previously held key roles, including being a Member of the Board of Directors and Chair of the Audit Committee at Cerecor Inc., Chief Business Officer at Kronos Bio, Inc., and Executive Director of Business Development at Regeneron Pharmaceuticals, Inc. Philip's journey also includes pivotal positions at MPM Capital, Gilead Sciences, Inc., Riverside Partners, The Wilkerson Group / IBM Healthcare, Regeneron Pharmaceuticals, and the University of Maryland School of Medicine.

Philip Gutry's multifaceted experience encapsulates a career dedicated to driving innovation and growth in the biopharmaceutical industry. His track record of successfully securing funding, strategic decision-making, and fostering partnerships underscores his commitment to advancing science and transforming it into tangible outcomes.

Philip Gutry
Add to my network

Location

San Francisco Bay Area